Skip to main content

Tauriga Sciences, Inc. Receives Tens of Thousands of Dollars Worth of Purchase Orders from International / Kosher Distributor(s)

Written by Customer Service on . Posted in Public Companies.

NEW YORK, NY, Dec. 26, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the“Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced it has received Tens of Thousands of Dollars worth of Purchase Orders from multiple International / Kosher Distributors. These Purchase Orders have been received by the Company, as a result of the Exhibitor Booth (# 7095) that it operated at Kosherfest 2019 – which took place on November 12-13, 2019 in Secaucus, New Jersey.  The Company has already received payment(s) and shipped product, concerning a substantial portion of the above-mentioned Purchase Orders.  The Company expects to realize this revenue, in connection with these above-referenced Purchase Orders, during both its current Quarter (October 1, 2019 – December 31, 2019) and its next Quarter (January 1, 2020 – March 31, 2020).
Moving forward, the Company continues to experience strong levels of interest from a broad array of additional International Distributors.  Most notably the Company is currently in late stage negotiations with a major United Kingdom (“UK” or “England”) based Kosher Distributor and is hopeful to receive an initial Purchase Order in the near term. The Company is also in discussions with International Distributors, from the following countries: Australia, Israel, France, Malaysia, Aruba, Barbados, and Canada.    ABOUT TAURIGA SCIENCES INC.Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases.  This CBD infused chewing gum product has been branded under the following name: Tauri-Gum™.  The Company is currently in production of three distinct flavors of Tauri-Gum™: MINT, BLOOD ORANGE, and POMEGRANATE.  On December 6, 2019 the Company announced that it completed the initial production run (thereby expanding its existing product lines) with the introduction of a 25mg Vegan CBD Isolate Infused vegan gummy (“gum drop”), branded under the name: Tauri-Gummies™.  Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.In addition, on March 11, 2019, the Company announced the official launch of its E-Commerce site – as part of its Tauri-Gum™ commercialization strategy.  This site can be accessed by visiting the following URL address:  www.taurigum.comThe Company has established corporate offices in both New York City (USA) and Barcelona (Spain).DISCLAIMER — Forward-Looking StatementsContact:CONTACT INFORMATION

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.